WET AGE RELATED MACULAR DEGENERATION
Clinical trials for WET AGE RELATED MACULAR DEGENERATION explained in plain language.
Never miss a new study
Get alerted when new WET AGE RELATED MACULAR DEGENERATION trials appear
Sign up with your email to follow new studies for WET AGE RELATED MACULAR DEGENERATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
One shot to save sight? gene therapy trial aims to end monthly eye injections
Disease control Recruiting nowThis Phase 3 study tests a one-time gene therapy called RGX-314 for wet age-related macular degeneration (AMD), a leading cause of vision loss. The goal is to see if a single treatment can control the disease as well as standard eye injections given every few months. About 714 ad…
Matched conditions: WET AGE RELATED MACULAR DEGENERATION
Phase: PHASE3 • Sponsor: AbbVie • Aim: Disease control
Last updated May 26, 2026 11:32 UTC
-
New hope for wet AMD patients: could a simple pill drain stubborn eye fluid?
Disease control Recruiting nowThis study tests whether an oral antibiotic (doxycycline) can help people with wet age-related macular degeneration (AMD) who still have fluid in their eye despite standard injections. About 50 participants will receive either doxycycline or a placebo for several months. The goal…
Matched conditions: WET AGE RELATED MACULAR DEGENERATION
Phase: PHASE2 • Sponsor: University of Iowa • Aim: Disease control
Last updated May 26, 2026 11:08 UTC
-
Can your genes predict the best eye injection for AMD?
Knowledge-focused Recruiting nowThis study looks at how a person's genes influence their response to two common eye injection treatments for wet age-related macular degeneration (AMD). About 630 adults aged 50 and older with untreated wet AMD will receive either ranibizumab or bevacizumab and be followed for 3 …
Matched conditions: WET AGE RELATED MACULAR DEGENERATION
Phase: PHASE3 • Sponsor: Parc de Salut Mar • Aim: Knowledge-focused
Last updated May 26, 2026 11:28 UTC